What does CUSIP 03969F109 represent in this 13F holders report?

CUSIP 03969F109 is the security identifier for RCUS - Arcus Biosciences, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held RCUS - Arcus Biosciences, Inc. - Common Stock in Q1 2021?

143 institutional investors reported RCUS - Arcus Biosciences, Inc. - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

Arcus Biosciences, Inc. - Common Stock (RCUS)

CUSIP: 03969F109

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock
Shares outstanding: 122,470,452
Total 13F shares: 44,736,322
Share change: +147,850
Total reported value: $1,254,917,338
Put/Call ratio: 392%
Price per share: $28.08
Number of holders: 143
Value change: +$7,899,154
Number of buys: 71
Number of sells: 74

Quarterly Holders Quick Answers

What is CUSIP 03969F109?
CUSIP 03969F109 identifies RCUS - Arcus Biosciences, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 03969F109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RCUS - Arcus Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Alphabet Inc.	13F	Company	4.1%	5,049,786	$131,092,000	—	31 Dec 2020	13F
PFM Health Sciences, LP	13F	Company	2.8%	3,373,460	$87,575,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	2.7%	3,255,091	$84,501,000	—	31 Dec 2020	13F
BVF INC/IL	13F	Company	2.2%	2,752,222	$71,448,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	1.9%	2,347,624	$60,944,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	1.8%	2,233,660	$57,986,000	—	31 Dec 2020	13F
EcoR1 Capital, LLC	13F	Company	1.8%	2,195,892	$57,005,000	—	31 Dec 2020	13F
Boxer Capital, LLC	13F	Company	1.7%	2,084,883	$54,124,000	—	31 Dec 2020	13F
Invus Financial Advisors, LLC	13F	Company	1.5%	1,842,077	$47,820,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	1.5%	1,822,855	$47,321,000	—	31 Dec 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	1.1%	1,376,393	$35,732,000	—	31 Dec 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.92%	1,132,562	$29,402,000	—	31 Dec 2020	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.7%	861,160	$22,356,000	—	31 Dec 2020	13F
TimesSquare Capital Management, LLC	13F	Company	0.68%	827,270	$21,476,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.62%	759,163	$19,708,000	—	31 Dec 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.6%	730,022	$18,951,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.53%	646,091	$16,772,000	—	31 Dec 2020	13F
HHLR ADVISORS, LTD.	13F	Company	0.51%	625,000	$16,225,000	—	31 Dec 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	0.46%	569,333	$14,780,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.44%	535,565	$13,903,000	—	31 Dec 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.41%	497,142	$12,905,000	—	31 Dec 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.4%	491,100	$12,749,000	—	31 Dec 2020	13F
MACQUARIE GROUP LTD	13F	Company	0.38%	462,364	$12,003,000	—	31 Dec 2020	13F
S.c.a. Candriam	13F	Individual	0.33%	409,006	$10,618,000	—	31 Dec 2020	13F
ALKEON CAPITAL MANAGEMENT LLC	13F	Company	0.33%	407,100	$10,568,000	—	31 Dec 2020	13F
Consonance Capital Management LP	13F	Company	0.32%	387,492	$10,059,000	—	31 Dec 2020	13F
Asymmetry Capital Management, L.P.	13F	Company	0.28%	348,408	$9,045,000	—	31 Dec 2020	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.26%	315,811	$8,198,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	0.25%	304,758	$7,911,000	—	31 Dec 2020	13F
Octagon Capital Advisors LP	13F	Company	0.24%	300,000	$7,788,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.23%	287,080	$7,453,000	—	31 Dec 2020	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.2%	250,000	$6,490,000	—	31 Dec 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.2%	245,300	$6,368,000	—	31 Dec 2020	13F
Parkman Healthcare Partners LLC	13F	Company	0.19%	231,758	$6,016,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.17%	204,789	$5,316,000	—	31 Dec 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.17%	204,233	$5,302,000	—	31 Dec 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.16%	198,754	$5,162,000	—	31 Dec 2020	13F
GREAT LAKES ADVISORS, LLC	13F	Company	0.16%	194,810	$5,057,000	—	31 Dec 2020	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.16%	194,539	$5,050,000	—	31 Dec 2020	13F
Sofinnova Investments, Inc.	13F	Company	0.15%	186,278	$4,836,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.15%	182,562	$4,739,000	—	31 Dec 2020	13F
MARSHALL WACE, LLP	13F	Company	0.13%	163,646	$4,248,000	—	31 Dec 2020	13F
Marshall Wace North America L.P.	13F	Company	0.12%	150,226	$3,901,000	—	31 Dec 2020	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.12%	144,787	$3,759,000	—	31 Dec 2020	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.1%	122,773	$3,187,000	—	31 Dec 2020	13F
ALPS ADVISORS INC	13F	Company	0.1%	117,318	$3,046,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.09%	108,285	$2,811,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.08%	95,513	$2,479,000	—	31 Dec 2020	13F
Swiss National Bank	13F	Company	0.08%	95,396	$2,476,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.08%	93,575	$2,429,000	—	31 Dec 2020	13F

Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q1 2021

As of 31 Mar 2021, Arcus Biosciences, Inc. - Common Stock (RCUS) was held by 143 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,736,322 shares. The largest 10 holders included Alphabet Inc., PFM Health Sciences, LP, BlackRock Inc., VANGUARD GROUP INC, FMR LLC, EcoR1 Capital, LLC, STATE STREET CORP, BOXER CAPITAL, LLC, BVF INC/IL, and Invus Financial Advisors, LLC. This page lists 143 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

143

Q1 2021 holders

143

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.